Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in CADL — Candel Therapeutics, Inc.

CIK 1214717 BOSTON, MA
Back to CADL Full portfolio

Position in CADL

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$16,181,515
+$11,107,885 QoQ
Shares Held
1,571,021
+51.7% QoQ
Ownership
2.05%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 138 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CADL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. CADL ranks #154 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in CADL

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $16,181,515 1,571,021
2026-03-31 $5,073,630 1,035,435
2025-12-31 $5,522,942 977,512
2025-09-30 $4,733,803 928,197
2025-06-30 $4,574,087 903,970
2025-03-31 $3,884,153 687,461
2024-12-31 $3,953,079 455,424
2024-09-30 $3,111,548 448,997
2024-06-30 $2,466,892 397,886
2024-03-31 $230,215 145,706
2023-12-31 $204,701 139,253
2023-09-30 $128,112 139,253
2023-06-30 $165,315 131,203
2023-03-31 $177,124 131,203
2022-12-31 $234,853 131,203
2022-09-30 $404,576 128,846
2022-06-30 $243,703 75,217
2022-03-31 $382,854 75,217
2021-12-31 $455,788 58,285
2021-09-30 $221,081 20,395